查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1493333

美國人工電子耳市場規模、佔有率和趨勢分析報告：按年齡層、最終用途、地區和細分市場預測，2024-2030 年

U.S. Cochlear Implants Market Size, Share & Trends Analysis Report By Age Group (Adult, Pediatric), By End-use (Hospitals, Clinics), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 70 Pages | 商品交期: 2-10個工作天內

價格

美國人工電子耳市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，美國人工電子耳市場規模預計將達到9.401億美元，2024年至2030年複合年成長率為6.08%。

美國殘障人士數量的不斷增加以及與老齡化相關的聽力損失的普遍存在正在推動美國市場對人工電子耳的需求。

根據美國耳聾和耳聾研究所 (NIDCD) 的數據，美國每 1,000 名兒童中就有 2 到 3 名患有明顯的聽力損失，據說美國每1,000 名嬰兒中約有1 名患有感音神經性聽力損失。 2019 年，美國食品藥物管理局(FDA) 批准為 5 歲及以上單側聽力損失 (SSD) 兒童植入人工電子耳，以幫助這些患者。

透過提高人們對聽力損失和人工電子耳益處的認知，這些組織將增加需求，促進對技術的更好理解，並推動市場成長。政府的措施著重於聽力殘障人士的治療價值和歧視問題，例如擴大美國人工電子耳的覆蓋範圍，將推動市場擴張。

美國人工電子耳市場報告亮點：

  • 按年齡層別分類，由於聽力損失盛行率不斷上升，2023 年成人佔據最大市場佔有率，超過 64.2%。預計 2024 年至 2030 年，兒科市場將以最快的複合年成長率成長。
  • 根據最終用途，診所業務在 2023 年佔據最大收益佔有率。診所，特別是耳鼻喉科診所，是人工電子耳服務的重要提供者，提供評估人工電子耳候選人、進行手術和提供術後護理的專業知識。
  • 診斷率的提高、聽力損失意識的提高、雙耳佩戴需求的增加以及政府支持計劃預計將成為推動這一成長的因素。
  • 2021 年 6 月，奧迪康醫療的 NeuroSystem 獲得了美國食品藥物管理局(FDA) 的上市前核准(PMA)，該產品適用於 18 歲及以上患有雙側重度至極重度感覺神經性聽力損失。當穿戴式科技透過人工電子耳產品進入美國市場時，這些人將從中獲得的好處有限。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章美國人工電子耳市場變數、趨勢、範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 美國人工電子耳市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章美國人工電子耳市場：年齡層估計及趨勢分析

  • 2023年及2030年按年齡族群分類的市場佔有率
  • 細分儀表板
  • 按年齡分類的美國人工電子耳市場前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 成人
  • 孩子

第5章美國人工電子耳市場：最終用途估計與趨勢分析

  • 2023 年及 2030 年最終用途市場佔有率
  • 細分儀表板
  • 美國人工電子耳市場依應用前景
  • 2018-2030年市場規模、預測及趨勢分析
  • 醫院
  • 診所
  • 其他

第6章美國人工電子耳市場：區域估算及趨勢分析

  • 2023 年和 2030 年按地區分類的市場佔有率佔有率
  • 美國人工電子耳市場按地區展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 西
  • 中西部
  • 東北
  • 西南
  • 東南

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
  • 公司簡介
    • Cochlear Ltd
    • MED-EL Medical Electronics
    • Oticon Medical
    • Advanced Bionics Corporation
    • Sonova Holding AG
    • Medtronic
    • Nurotron Biotechnology Co., Ltd
    • ZPower, LLC
    • Widex A/S
Product Code: GVR-4-68040-281-5

U.S. Cochlear Implants Market Growth & Trends:

The U.S. cochlear implants market size is anticipated to reach USD 940.1 million by 2030, growing at CAGR of 6.08% from 2024 to 2030, according to a new report by Grand View Research, Inc. The number of individuals with hearing impairments and the increasing prevalence of age-related hearing loss in the U.S. is driving the demand for cochlear implants in the U.S. market.

According to the National Institute of Deafness and Other Communication Disorders (NIDCD), 2 to 3 out of every 1000 children have hearing loss that can be identified in the U.S. It also stated that roughly 1 in 1000 live infants are affected by sensorineural unilateral hearing loss in the country. The U.S. Food and Drug Administration (FDA) authorized cochlear implantation in 2019 for children with single-sided deafness (SSD) who were five years or older to help these patients.

By raising awareness about hearing loss and the benefits of cochlear implants, these organizations increase demand and promote a better understanding of the technology, which would drive the market's growth. Government initiatives focusing on therapeutic value and discriminatory issues spurred by people with impairments, such as expanded coverage for cochlear implants in the U.S. promote market expansion.

U.S. Cochlear Implants Market Report Highlights:

  • Based on age group, the adult segment held the largest market share of over 64.2% in 2023 owing to the rising prevalence of hearing loss. The pediatric segment is expected to grow at the fastest CAGR from 2024 to 2030
  • Based on end-use, the clinics segment accounted for the largest revenue share in 2023. Clinics, particularly ENT clinics, are essential providers of cochlear implant services, offering expertise in evaluating candidates for implants, conducting surgeries, and providing post-operative care
  • The rising diagnosis rates, growing awareness of hearing impairment, growing desire for bilateral fittings, and supportive government programs are some factors expected to drive this growth.
  • In June 2021, Oticon Medical announced that the Neuro System, the company's product for treating individuals 18 years of age or older with bilateral severe-to-profound sensorineural hearing loss, has received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA). These individuals stand to benefit limitedly from wearable technology, by entering the U.S. market with its cochlear implant products.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Age Group
    • 1.2.2. End-use
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Age Group outlook
    • 2.2.2. End-use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Cochlear Implants Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. Cochlear Implants Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Cochlear Implants Market: Age Group Estimates & Trend Analysis

  • 4.1. Age Group Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. Cochlear Implants Market by Age Group Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Adult
    • 4.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.6. Pediatric
    • 4.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (USD Million)
    • 4.6.2. Adult Unilateral Implants
      • 4.6.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.6.3. Adult Bilateral Implants
      • 4.6.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (USD Million)
    • 4.6.4. Pediatric Unilateral Implants
      • 4.6.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.6.5. Pediatric Bilateral Implants
      • 4.6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (USD Million)

Chapter 5. U.S. Cochlear Implants Market: End-use Estimates & Trend Analysis

  • 5.1. End-use Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. U.S. Cochlear Implants Market by Application Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Hospitals
      • 5.4.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.2. Clinics
      • 5.4.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.4.3. Others
      • 5.4.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. U.S. Cochlear Implants Market: Region Estimates & Trend Analysis

  • 6.1. Regional Market Share, 2023 & 2030
  • 6.2. U.S. Cochlear Implants Market by Region Outlook
  • 6.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 6.3.1. West
      • 6.3.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 6.3.2. Midwest
      • 6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.3. Northeast
      • 6.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.4. Southwest
      • 6.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.5. Southeast
      • 6.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company heat map analysis, 2023
  • 7.4. Company Profiles
    • 7.4.1. Cochlear Ltd
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. MED-EL Medical Electronics
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Oticon Medical
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Advanced Bionics Corporation
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Sonova Holding AG
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Medtronic
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Nurotron Biotechnology Co., Ltd
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. ZPower, LLC
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Widex A/S
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 List of Secondary Sources
  • Table 3 U.S. Cochlear Implants Market, By Age group, 2018 - 2030 (USD Million)
  • Table 4 U.S. Cochlear Implants Market, By End-use, 2018 - 2030 (USD Million)
  • Table 5 U.S. Cochlear Implants Market, By Region, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. Cochlear Implants market: market outlook
  • Fig. 9 U.S. Cochlear Implants competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 U.S. cochlear implants market driver impact
  • Fig. 14 U.S. cochlear implants market restraint impact
  • Fig. 15 U.S. cochlear implants market: Age Group movement analysis
  • Fig. 16 U.S. cochlear implants market: Age Group outlook and key takeaways
  • Fig. 17 Adult market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Pediatric market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Adult unilateral implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Adult bilateral implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Pediatric unilateral implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Pediatric bilateral implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. cochlear implants market: End-use movement analysis
  • Fig. 24 U.S. cochlear implants market: End-use outlook and key takeaways
  • Fig. 25 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Clinics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 U.S. cochlear implants market: regional movement analysis
  • Fig. 29 U.S. cochlear implants market: regional outlook and key takeaways
  • Fig. 30 West market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Midwest market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Northeast market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Southwest market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Southeast market estimates and forecasts, 2018 - 2030 (USD Million)